From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

from TCTMD

A U.S. Food and Drug Administration advisory panel effectively gave an overwhelming endorsement of the Absorb everolimus-eluting bioresorbable vascular scaffold during a daylong session devoted to the investigational "dissolving" stent. In total, nine panel members of the FDA's Circulatory System Devices Panel felt the benefits of the Absorb BVS stent outweighed the risks. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063